(Q42608997)

3 November 2017

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia (English)

1 reference

3 November 2017

Yuichiro Shindo

1

1 reference

3 November 2017

Ryota Ito

2

1 reference

3 November 2017

Daisuke Kobayashi

3

1 reference

3 November 2017

Masahiko Ando

4

1 reference

3 November 2017

Motoshi Ichikawa

5

1 reference

3 November 2017

Akira Shiraki

6

1 reference

3 November 2017

Yasuhiro Goto

7

1 reference

3 November 2017

Yasutaka Fukui

8

1 reference

3 November 2017

Mai Iwaki

9

1 reference

3 November 2017

Junya Okumura

10

1 reference

3 November 2017

Ikuo Yamaguchi

11

1 reference

3 November 2017

Tetsuya Yagi

12

1 reference

3 November 2017

Yoshimasa Tanikawa

13

1 reference

3 November 2017

Yasuteru Sugino

14

1 reference

3 November 2017

Joe Shindoh

15

1 reference

3 November 2017

Tomohiko Ogasawara

16

1 reference

3 November 2017

Fumio Nomura

17

1 reference

3 November 2017

Hideo Saka

18

1 reference

3 November 2017

Masashi Yamamoto

19

1 reference

3 November 2017

Hiroyuki Taniguchi

20

1 reference

3 November 2017

Ryujiro Suzuki

21

1 reference

3 November 2017

Hiroshi Saito

22

1 reference

3 November 2017

Takashi Kawamura

23

1 reference

3 November 2017

Yoshinori Hasegawa

24

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

American Journal of Respiratory and Critical Care Medicine

3 November 2017

1 reference

3 November 2017

188

1 reference

3 November 2017

985-995

1 reference

3 November 2017

8

1 reference

Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia

3 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Rethinking the concepts of community-acquired and health-care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Health care-associated pneumonia: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Is healthcare-associated pneumonia a distinct entity needing specific therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201301-0079OC

10.1164/RCCM.201301-0079OC

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference